Immunization News and Research

RSS

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

Black, indigenous, and people of color (BIPOC) who were infected with COVID-19 experienced greater negative aftereffects in health and work loss than did similarly infected white participants, new research finds.

1 Feb 2024

Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years

Study shows that a single dose of typhoid conjugate vaccine provides over four years of protection against typhoid fever in Malawian children, proving effective across all age groups.

31 Jan 2024

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Researchers found that neonates born to mothers with SARS-CoV-2 infection face an increased risk of respiratory distress, potentially due to an inflammatory response triggered by prenatal exposure.

29 Jan 2024

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine's (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

25 Jan 2024

Montana’s effort to expand religious exemptions to vaccines prompts political standoff

Montana lawmakers are in a standoff with the state's health department over a package of sweeping changes to child care licensing rules that includes a disputed provision to allow religious exemptions to routine vaccinations for children and workers.

19 Jan 2024

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

It has been 4 years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging.

19 Jan 2024

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

19 Jan 2024

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers investigate the need for prioritizing COVID-19 booster vaccination.

19 Jan 2024

INSIS study unveils secrets of rare vaccine events, shaping future immunizations

A University of Alberta professor is co-leading a new international vaccine safety network to examine why some people who received a COVID-19 vaccine experienced very rare adverse events associated with the vaccine.

17 Jan 2024

CDC immunization schedule lacks clinician communication tools

In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to "raise its persuasive communications game" on adult immunization to clinicians and the public.

11 Jan 2024

Sickle cell patients lag behind in COVID vaccination despite higher risks

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they're also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.

10 Jan 2024

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Researchers at Karolinska Institutet in Sweden have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.

10 Jan 2024

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

10 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

The global prevalence and regional differences in the intention to receive the monkeypox.

4 Jan 2024

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

2 Jan 2024

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

2 Jan 2024

Immunization News and Research

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

Montana’s effort to expand religious exemptions to vaccines prompts political standoff

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

INSIS study unveils secrets of rare vaccine events, shaping future immunizations

CDC immunization schedule lacks clinician communication tools

Sickle cell patients lag behind in COVID vaccination despite higher risks

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

UVA biomedical engineer unveils hidden immune symphony during pregnancy

Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News